Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.48524 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.4741 | 58 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.46643 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.428 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.43215 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.7423 | 61 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.70997 | 61 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.46664 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.46601 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.47195 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.4661 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.45024 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.46539 | 57 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.47096 | 58 |